glp 1 medication for pcos CUAnschutz researchers have published a proof-of-concept study demonstrating that injectable semaglutide may offer meaningful reproductive benefits women with polyendocrine metabolic ovarian syndrome (PMOS), formerly known as PCOS. “Women with PMOS Rising use of GLP-1 medications

Weigh yourself in the morning, after using the bathroom, before eating or drinking, wearing minimal clothing

Cosmos Study October 14, 2025 Dual-Team Study Team A:Kersten Bartelt, RNEric Barkley Team B:Joel Jones, PharmDJoe Deckert, PhD Key Findings Among non-diabetic patients without chronic kidney disease (CKD), there was a minimal increase of 0.01 mg/dL to 0.02 mg/dL in serum creatinine in the months following initiation of semaglutide, liraglutide, or tirzepatide

[1] [5] Rotate injection sites with each weekly dose, avoiding injecting into the same exact spot

B12 supplementation is common among GLP-1 users, and many compounded formulations now include B12 in the blend or tirzepatide with B12

doi:10.1002/hep.21635